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ABSTRACT 
 
Obesity and type 2 diabetes are characterized by mild systemic inflammation, enlargement of fat 
depots, and uncontrolled release of free fatty acids into the circulation; they are both strongly 
associated with metabolic and cardiovascular disorders, such as dyslipidemia, coronary heart 
disease, high blood pressure and myocardial infarct.  
White adipose tissue has been widely accepted to be much more than a static fuel storage organ. Its 
capability of regulating homeostatic and metabolic mechanisms has been underlined during the last 
20 years; several studies have proposed adipose tissue as an endocrine organ, secreting hormones, 
adipokines and other biologically active agents acting locally or in a systemic manner.  
Adipose tissue depots are not uniform; their characteristics change in different areas of the body, 
displaying distinct structural and functional properties and having different putative roles in 
pathologies.  
Epicardial adipose tissue (EAT) is a peculiar adipose tissue depot, which has recently been the 
center of many studies. It’s located predominantly on the right free wall of the heart, surrounding 
coronary arteries and being directly in contact with the myocardial layer. EAT has been shown to 
secrete many different adipokines and is supposed to have a role in the generation and progression 
of coronary artery diseases.  
The aim of this thesis was to better characterize EAT and the underlying myocardial layer. 
In paper 1 we investigated adipocyte cell size and adiponectin secretion comparing EAT, visceral 
AT (VAT) and subcutaneous AT (SAT). EAT resulted to have smaller adipocytes and lower 
adiponectin secretion levels. Adipocyte size, both in EAT and in SAT, is positively related with 
insulin resistance, shows negative association with local adiponectin gene expression, and bigger in 
subjects with coronary artery disease. Adiponectin gene expression is significantly lower in EAT 
than in SAT. 
In paper 2 we focused our attention on the effect of diabetic state on EAT, showing higher MCP-1, 
CD-68, lower adiponectin level, and bigger adipocytes in subjects with than those without diabetes.  
We also analyzed thorough immunohistochemistry and present as unpublished data, the 
characteristics of fat and macrophagic infiltration of the myocardium of the same cohort of patients.  
Additionally, the result of a one year internship conducted at Lipid Laboratory in KI Sweden, has 
been included in the thesis, as paper 3. Leaving the subject of EAT, the paper is focused on adipose 
tissue and it’s molecular and genetic aspects in obesity. Since the gene Niemann-Pick C1 (NPC-1) 
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has recently being implicated in susceptibility to obesity, through a genome wide association study, 
we dig into the relationship between NPC-1 and obesity in humans. The analysis of NPC-1 mRNA 
ad protein in obesity, showed that NPC1 mRNA was significantly increased in obese individuals in 
SAT and VAT and down-regulated by weight loss. NPC-1 mRNA was enriched in isolated fat cells 
of WAT, in SAT versus VAT, but not modified during adipocyte differentiation. NPC-1 protein 
mirrored expression of mRNA in lean and obese individuals 
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1. INTRODUCTION 
 
1.1 Obesity 
 
Obesity (defined as a body mass index (BMI) > 30 kg/m2) is the result of a prolonged imbalance 
between caloric intake and energy expenditure. 
In recent years, the prevalence of overweight and obesity has increased in almost all developed 
countries (Prentice 2006). Recent estimates for the prevalence of obesity among adults are 36% in 
the United States (Flegal 2012) and  24% in Canada (Public Health Agency of Canada 2012).  
European Countries compared to the United States show a lower prevalence of obesity; recent data 
registered a prevalence of obesity of 9% for females and 10.7% for males in Italy (Micciolo 2010). 
The World Health Organization has shown that obesity levels have reached epidemic proportions 
worldwide with approximately 2·3 billion adults predicted to be overweight or obese by the year 
2015 (WHO 2005). 
The interest of research in obesity is easily explained by a recent meta-analysis, which confirms the 
association of obesity with all-cause mortality. (Flegal 2013)  
1.2 Adipose tissue as an endocrine organ 
Adipose tissue is composed by many different cell types. Main component are the adipocytes, 
which derive from mesenchymal stem cells (MESCs), common precursors for adipocytes, 
osteoblasts, myocytes and chondrocytes (Rosen 2006). MESCs initially develop into pre-
adipocytes, committed precursors to the two main adipocytes types: white (WAT) and brown 
(BAT) adipocytes (Rosen 2006). These two types of adipocytes are different in both morphology 
and function: white adipocytes are spherical cells with ~90% of their volume made up of a single 
lipid droplet and store energy for the metabolic needs of the organism; whereas brown adipocytes 
are polygonal cells with a roundish nucleus and several cytoplasmic lipid droplets, with many 
packed mitochondria expressing of uncoupling protein 1 (UCP1) and they are specialized in 
burning energy for thermogenesis.  
WAT is the main triacylglycerides (TG) storage depot of the body and tightly regulates TG 
mobilization. In conditions of excessive energy, fatty acid (FFA) hydrolysis occurs. Once within the 
cell, FFAs are hydrolysed by acyl-CoA-synthase to form acyl-Co-A, which may be metabolized in 
the TG synthesis pathway. With negative energy balance the process of lipolysis takes place, 
resulting in mobilisation of lipids from adipocytes under the influence of hormonal factors such as 
insulin (Vàzquez-Vela 2008).  
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Besides the role of energy storage, WAT is known to be a complex organ capable of producing and 
secreting a huge amount of molecules, called adipokines. Through the secretion of adipokines, AT 
is capable of modulating its own metabolic activity in an autocrine manner, and also to interact with 
other tissues both at local and systemic levels in a paracrine and endocrine manner (Vàzquez-Vela 
2008).  
The number of discovered hormones and cytokines secreted by adipocytes has expanded rapidly 
through the recent years. A simplified model of adipocyte activities is shown in Figure 1. 
 
Figure 1. Simplified model of adipocytes functions 
 
Besides adipocytes, AT contains a stromal-vascular matrix (SVM), including fibroblastic 
connective tissue cells, leukocytes, macrophages (MG), and pre-adipocytes, which may have a role 
in the secretion of many cytokines. The release of chemoattracting molecules (such as Monocyte 
chemoattractant protein-1 (MCP-1)),  from the adipocytes, stimulates MG migration to the depot, in 
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a process called chemotaxis, further exacerbating inflammation and adipocyte dysfunction.  MG 
infiltration of AT is  positively correlated to the size of adipocytes and to insulin resistance.  
 
In situations of nutrient excess, AT can respond rapidly with adipocyte hypertrophy and  
hyperplasia. This process leads to the production of higher amounts of inflammatory adipocytes and 
the arrival to a “critical size”, specific and different in each AT depot. When reaching the “critical 
size” endoplasmic reticulum (ER) stress and subsequent cells death are triggered. It has been shown 
that a large number of MG infiltrate AT to remove remnants of dead adipocytes. It’s possible to 
identify MG surrounding dead adipocytes, forming characteristic structures called “crown-like 
structures” (CLS) (Smorlesi 2012). Figure 2 and 3. 
 
 
 
 
 
 
 
 
 
 
 11 
                                                              
                                                    
Figure 2. Simplified model of adipose tissue hypertrophy, inflammation and 
recruitment of macrophages. 
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Figure 3. Himmunohistochemistry details 
of human epicardial adipose tissue:  
A. Vase packed with neutrophiles; 40x 
hematoxylin eosin; 
B.  Crown-like structures macrophages 
surrounding an adipocyte:400x anti- 
CD68 and hematoxylin 
 
 
 
 
 
 
MGs are heterogenic in both function and surface markers; they have a highly plastic phenotype in 
response to cytokines and microbial products of microenvironmental stimuli.  Main classifications 
are: M1 classically activated MGs and M2 alternatively activated MGs. M1 are induced by LPS and 
interferon-gamma and produce proinflammatory cytokines and reactive oxygen species, and are 
capable of inducing Th1-polarized T-cell responses. M2, which can be induced by IL-4 and IL-13, 
are generally supportive of antiinflammatory processes driven by IL-10, playing a role in tissue 
repair. Lumeng et al reported that in mice, diet-induced obesity leads to a shift in the activation state 
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of AT MGs from M2 to M1 state, contributing to insulin resistance (Lumeng 2007). Furthermore it 
has been reported that adiponectin is a regulator of MG polarization (Fujisaka 2009). 
Although there is a clear association of obesity and insulin resistance with MG infiltration of AT, 
the dominant phenotype of AT MG is still an open debate.  
 
1.3 Adipose tissue depot-specific characteristics and their impact on the association with 
diseases 
Since 1956 (Vague 1956) the notion that different distribution of AT can influence the 
predisposition of metabolic diseases, has raised great interest. Different depots are characterized by 
differences in their structure, expression profiles, responsiveness to endocrine and nervous stimuli, 
as well as local supply of oxygen, nutrients and hormones, resulting in different putative roles in 
pathologies. Preadipocytes isolated from different depots and cultured under the same conditions, 
resulted in mature cells maintaining fat depot-specific characteristics (Tchkonia et al. 2002, 2005). 
The two main subgroups of WAT are subcutaneous (SAT) and visceral AT (VAT). 
SAT is the AT under the skin, located in the hypoderms. It’s further divided into superficial and 
deep SAT (Smith et al. 2001, Miyazaki et al. 2002, Walker et al. 2007).  
VAT on the contrary, surrounds inner organs in the abdominal cavity and mediastinum. Main 
localization of VAT is the abdominopelvic cavity.  Intrabdominopelvic AT includes intraperitoneal 
(further divided into omental and mesenteric AT) and extraperitoneal (further divided into 
intraabdominal (retroperitoneal and preperitoneal) and intrapelvic) AT. VAT includes also smaller 
amounts of fat  localized in the mediastinum (intrathoracic or paracardial fat) and around specific 
organs, such as the heart (epicardial AT), stomach (epigastric fat tissue) and blood vessels 
(perivascular adipose tissue). (Shen 2003) Figure 4. 
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Figure 4. Adipose tissue depots classifications 
Main differences between VAT and SAT have been studied in obese individuals. Subcutaneous 
adipocytes seems to have a higher differentiation potential (Walker et al. 2007), whereas visceral 
adipocytes are smaller (Fried 1993) with a higher content of mitochondria, with higher respiratory 
rates (Kraunsoe 2010); moreover visceral adipocytes are characterized by lower basal and NA-
induced lipolysis (Ray 2009; Fried 1993), higher insulin-stimulated glucose uptake (Virtanen 2002) 
and higher lipolysis rate (Hoffstedt 1997). Visceral adipocytes seem to be more fragile and reach 
the critical death size earlier than subcutaneous adipocytes. In fact VAT shows higher density of 
CLS (Smorlesi 2012). 
Differences are seen not only in adipocytes, but also in the tissue in toto, in different depots; in 
particular: SAT seems to have a more dense vascularization due to higher angiogenic potential 
(Gealekman 2011); Regarding adipokines secretion VAT secretes more pro-inflammatory cytokines 
and lower level of adiponectin (Fontana 2007; Yang 2008; Van Harmelen 1998), also according to 
a higher MG infiltration (Cancello 2006). 
Due to its characteristics and its anatomical position, VAT seems to be involved in the onset of 
hyperglycaemia, hyperinsulinemia and eventually insulin resistance. According to the ‘portal 
hypothesis’ the excess of VAT, due to both its high lipolytic activity and its drainage into the portal 
system, results in high levels of FFA in blood plasma, leading to impaired insulin responsiveness of 
the liver (Miyazaki 2002) (Heilbronn 2004). 
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SAT is indeed considered as less metabolically active than VAT, with gluteofemoral AT mass 
considered to have even protective features on the metabolic syndrome (Snijder 2005, Buemann 
2006). 
In normal conditions adipose tissue maintains the balance between storage and release of FFA into 
circulation. With overnutrition and an imbalance between energy intake and energy expenditure, 
the capacity of adipose tissue to store lipids and hold balance, reach saturation. Consequently, non-
AT are exposed to excessive amount of FFA, which can lead to accumulation of ectopic fat and 
lipotoxicity, especially in the liver, skeletal muscles, heart and pancreas. 
Ectopic fat deposition can lead to endoplasmic reticulum (ER) stress, cells death and lastly, organ 
disfunction (Borradaile & Schaffer 2005).  
 
1.4 Fat and the heart 
Recently there has been particular interest in human fat in the heart. The fat of the heart is 
composed by different kinds of TG storages. Heart and coronaries are surrounded by significant 
amount of AT. AT around all arteries is called perivascular AT (PVAT). PVAT surrounding the 
coronaries is part of epicardial AT (EAT); externally to the pericardium there is pericardial AT. 
Another type of fat is myocardial fat, which refers to the storage of TG droplets within 
cardiomyocytes.  
1.4.1 Epicardial Adipose Tissue 
The locational, embryological and vascularization differences between EAT and pericardial AT, 
account for the different interest that those tissues have aroused. EAT is located between the 
myocardium and the visceral pericardium, and originates from the splanchnopleuric mesoderm; on 
the contrary, pericardial AT is located on the external surface of the parietal pericardium, 
originates from the primitive thoracic mesenchyme and is vascularized from non coronary sources 
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(Iacobellis and Bianco 2011). 
 
Figure 5. Anatomy of epicardial adipose tissue 
EAT covers 80% (range 56-100%) of the surface area of the human heart (Rabkin 2007); it may 
have a supportive mechanical purpose, attenuating vascular tension and torsion and participating 
in coronary remodeling. EAT is predominantly located on the right-ventricular free wall and on 
the left ventricular apex, so that the coronary arteries and their main epicardial branches are 
embedded in it (Rabkin 2007, Iacobellis 2008). EAT adipocytes have a higher rate of FFA uptake 
and secretion and may act as a local energy supplier and buffer for preventing toxic levels of FFA 
in the myocardium  (Marchington 1990). Recent data suggest that EAT thickness may directly 
associate with coronary artery disease (CAD), hypertrophy and also left ventricular mass in 
healthy subjects and visceral fat, independently of BMI (Iacobellis 2011, Corradi 2004). A recent 
study analyzed the effect of weight loss through very-low-calorie diet, exercise or bariatric surgery 
on EAT thickness; EAT reduction was quicker and higher than the decrease in BMI, waist 
circumference and body weight, resulting in an independent relation with the changes in systolic 
blood pressure, insulin sensitivity and left ventricular mass and function (Izzo 2011).  
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Around the coronaries the distance between PVAT and adventitia measures less than 0,1 mm with 
no anatomic barrier between the two tissues.  Adipocytes have been reported even to encroach the 
outer adventitial region (Chatterjee 2009, Iacobellis 2007) and  it has been postulated that PVAT 
might promote an inflammatory environment on the adventital layer. Interestingly atherosclerosis 
appears to be virtually suppressed in intramyocardial (buried) segments of coronary arteries 
(Arslan 2009). It has been recently observed a correlation of adventitial inflammatory lymphocytic 
and macrophage infiltration with severity of intimal disease (Tavora 2009), more common in 
lesions with unstable plaque and necrotic core. 
 
Figure 6. Himmunohistochemistry, structure of human epicardial adipose tissue: 10x 
hematoxylin eosin; 
 
Higher expression and secretion of inflammatory adipokines and chemokines (TNF-alfa, IL-8, 
MCP-1, serum amyloid A, IL-1beta and IL-6) and infiltration of chronic inflammatory cell 
(machrophage, lymphocytes and basophilis), have been reported in EAT when compared to SAT 
from obese cardiovascular patients (Mazurek 2003, Fain 2010, Chen 2010 e Beker). 
Several studies have evaluated alterations in adipokines expression in EAT in pathological states as 
CAD, MS and DM2 (Table 1). 
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Adipokine/CD Protein/mRA Phatological state Expression References 
ActivinA mRNA DM2 ↑    (1). 
Adiponectin mRNA CAD ↓    (2, 3, 4, 16). 
 Protein  CAD ↓    (5). 
 mRNA CAD =    (6, 7, 8, 15). 
 mRNA DM2 =    (14). 
 mRNA MS ↓    (14). 
Adrenomedullin mRNA/Protein CAD ↑    (8, 9). 
Angiopoietin-2 mRNA DM2 ↑    (1). 
CD14 mRNA DM2 ↑    (1). 
CD68 mRNA CAD ↑    (15). 
CD150 mRNA CAD ↑    (15). 
CD163 mRNA CAD ↑    (15). 
CD206 mRNA CAD ↑    (15). 
CCR2 mRNA CAD ↑    (15). 
Chemerin mRNA/Protein CAD ↑    (2). 
GLUT4 mRNA CAD ↓    (9). 
IL-1Ra mRNA CAD     (15, 16). 
 mRNA DM2 ↑    (10). 
 mRNA MS ↑    (10). 
IL-6 mRNA CAD ↑    (3, 4, 6, 7, 15). 
 mRNA CAD =    (6). 
IL-10 mRNA CAD ↑    (6, 15). 
 mRNA DM2 ↑    (10). 
 mRNA MS ↑    (10). 
IL-18 mRNA CAD ↑    (11). 
IKK-β Protein/mRNA CAD ↑    (12). 
JNK Protein/mRNA CAD ↑    (12). 
Leptin mRNA CAD ↑    (7, 3, 15). 
 mRNA DM2 =    (14). 
MCP-1 mRNA CAD ↑    (7, 6, 15). 
 mRNA CAD =     (6). 
NGF mRNA CAD ↑    (15). 
NFkB Protein/mRNA CAD ↑    (12, 15). 
NPR-A mRNA CAD =    (7). 
NPR-C mRNA CAD ↑    (7). 
PPAR-γ mRNA DM2 =    (10). 
 mRNA MS =    (10). 
 mRNA CAD =    (7). 
RANTES mRNA CAD ↑    (16). 
RPB4  mRNA CAD ↑    (9). 
Tpl2 mRNA CAD     (15). 
TNF-alfa mRNA/Protein CAD ↑    (2, 3, 6, 15). 
 mRNA CAD =    (6). 
Visfatin  mRNA CAD ↑    (3). 
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Adipokine/CD Protein/mRA Phatological state Expression References 
     
Reactive  
oxygen/redox 
genes 
    
GPX-3 mRNA CAD ↑    (15). 
P47phox mRNA CAD ↑    (15). 
eNOS mRNA CAD ↑    (15). 
HMOX-1 mRNA CAD ↑    (15). 
SOD-2 mRNA CAD ↑    (15). 
     
Table I: Main literature on the subject; References: 1: Greulich 2011; 2: Gao 2011; 3: Chen 
2010; 4: Eiras 2008; 5: Iacobellis 2005; 6: Hirata 2011; 7: Skabal 2011; 7: Shibasaki 2010; 8: 
Silaghi 2005; 9: Salgado-Somoza 2011; 10: Sacks 2011; 11: Dozio 2012; 12: Baker 2008; 13: 
Teijeira-Fernandez 2009; 14: Teijeira-Fernandez 2010; 15. Sacks 2011; 16. Karastergiou 2010 
 
Form the recent leterature we can then generally deduce that EAT expands and becomes hypoxic 
and dysfunctional in metabolic and CAD states, starting to recruit phagocytic cells. This process 
reduce the production of protective in favor of inflammatory adipocytokines such as IL-6, TNFα. 
Adipokines produced by the PVAT component of EAT might interact with cells in each of the 
artery wall layers by diffusion, representing an “outside-in” component, in addition to the 
traditional endothelial and intimal layers “inside-out” view to atherogenesis. Moreover the vasa 
vasorum, which proliferates during vascular inflammation, are interspersed in perivascular AT.  
Adipokines produced by PVAT can access directly into the vasa vasorum, and be delivered into the 
intima.  
PVAT seems to contribute to smooth muscle cell proliferation and migration. Takaoka et al in 
mouse and rat models of vascular injury, showed a rapid phenotypic modification of perivascular 
AT associated with infiltration of inflammatory cells and foam cells, induced by endovascular 
injury (Takaoka 2010).   
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In a porcine model of coronary artery balloon angioplasty, Jabs et al. identify pervascular tissue as 
a main source of inflammatory response, leucocyte chemoattractant factors and macrophage 
activation (Jabs 2007). 
PVAT can modulate also vasoreactivity, in a mechanism that appears to be both endothelium 
dependent, via relase of nitric oxide (NO), and endothelium-independent, via generation of 
hydrogen peroxide (Greenstein 2009). Greenstein et al. in a recent study in human, underlined 
obesity-realted changes in PVAT vasoactive properties. The inhibition of vascular contraction in 
healthy subjects, was lost in obese patients with metabolic syndrome. The same lost of the dilator 
effect of PVAT was observed from Hosogai et al in (Hosogai 2007) a model of low oxygen or 
hypoxia.  
 
Besides their possible role on the coronary vessels, EAT adipokines have been proposed to interact 
directly with cardiomyocytes. The absence of any fascia (seen on the contrary in skeletal muscle) 
separating the adipocytes and the myocardial layer, allows a direct paracrine crosstalk between the 
tissues.  
The effects of adipocytes derived factors on cardiomyocytes have been evaluated in a series of in 
vitro studies (Lamounier-Zepter 2006; Lamounier-Zepter 2009; Look 2011; Look 2008; Greulich 
2012): adipocyte-derived resulted to have a negative inotropic effect on isolated cardiomyocytes by 
reducing sarcomere shortening and intracellular Ca 
2+
 fluxes (Lamounier-Zepter 2006; Greulich 
2012); adipocyte conditioned medium on isolated perfused rats heart showed direct and acute 
suppression of heart contraction due to adipocyte derived factors, that was completely reversed after 
washout (Look 2008 and 2011). The effects of some well known proinflammatory cytokines were 
tested at the same concentrations detected in AT conditioned medium: TNF-α, IL-6, IL-1beta 
resulted to be not responsible for the cardiodepressant effect. 
Adiponectin, a cytokine secreted mainly by adipocytes, with anti-inflammatory, insulin-sensitizing 
and anti-atherogenic properties has been lately proposed to exert protective actions also on 
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cardiomyocytes . In vitro studies demonstrated an antiapoptotic effect of full-length adiponectin on 
cardiomyocytes, largely via an AMP-kinase-mediated signaling pathway (Shinmura 2007). 
Adiponectin seems also to exerts its beneficial metabolic effects through a lowering of cellular 
ceramide in left ventricular of mice (Holland 2011). Ceramide is considered an enhancer of 
apoptotic susceptibility in the heart (Holland 2011, Park 2009). 
1.4.2 Myocardial fat infiltration 
 
Intrinsic cardiac metabolism of the adult heart depends primarily (50-70%) on the utilization of 
fatty acids for oxidative phosphorylation and generation of ATP, while the remainder (w30%) is 
principally obtained via metabolism of glucose. Although the myocardium presents an extremely 
high rate of lipolytic turnover and abundantly express PPAR-α, a key regulator of the genes 
involved in fatty acid oxidation, the healthy heart has a relatively limited capacity for storing lipids 
(Paul 2008). A decrease in glucose transport, glycolysis, and glucose oxidation, together with an 
increase in fatty acid uptake and oxidation, is typically observed in the heart pathological state such 
as obesity and diabetes (Stanley 2005, Abel 2008). 
In the human aging heart, myocardial fatty acid oxidation is reduced, with an increase of TG 
storage which correlates to the age-related decline in diastolic left ventricular function (van der 
Meer 2008). A dose dependent increase in LD storage has been reported during fasting (Suzuki 
2001) or in pathological conditions, such as ischaemia (Jodalen 1985; Greve 1990) diabetes, obesity 
(McGavock 2006) and metabolic syndrome (Marfella 2009).  
 
Little is know about the characteristics of myocardial fat infiltration in CAD and in relation to EAT. 
As in the liver, pancreas and other organs, also accumulation of TG in the heart is supposed to lead 
organ disfunction.  
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2. Adiponectin gene expression and adipocyte diameter: a comparison between epicardial 
and subcutaneous adipose tissue in men (paper1) 
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3. Inflammatory profile in subcutaneous and epicardial adipose tissue in men with and 
without diabetes. (paper 2) 
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4. Characterization of myocardial fat and macrophages infiltration in human 
 
4.1 Material and Methods 
A number of 45 subjects were included in the study.  
All participants were selected as described in paper number 1 and 2. 
Serum collection and analysis have been previously described in paper 1 and 2.  
Atrial fragments (1 gr) were collected and stored for immunohistochemistry during cardiosurgery. 
 
Immunohistochemistry: 
Freshly isolated atrial tissue was fixed in 4% formaldeid 0.1M sodium PB, pH7.4, overnight at 4°C, 
and later embedded in paraffin block. The paraffin-embedded tissue block were sectioned at 4 μm 
thickness on a microtome  and transferred onto glass slides for immunohistochemistry. 
Deparaffinization of the slides was performed trough 2 changes of xylene for 10 minutes. Slides 
were transferred to 100% alcohol, for 2 changes, 2 min each, and then transferred once through 
95%, 80% alcohols respectively for 2 min each, followed by a quick passage into pure distilled 
water. Antigen retrieval microwave heating (750W) technique with citrate buffer solution (pH 6.00) 
was applied. Saturation of non specific binding sites was performed with Universal Protein 
Blocking Reagent (150 um for each glass slide 30 minutes, room temperature).  
 
Evaluation of mitochondial and endoplasmic stress: Grp75 and Grp78. 
Primary antibody: Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA goat polyclonal anti-Grp78 
(sc-1050) and rabbit polyclonal anti-Grp75 (sc- 13967) (dilution 1:100 in PBS). 
Secondary antibody: kit rabbit ABC-peroxidase staining system (Santa Cruz Biotechnology Inc) 
and DPX; 
Analysis: Intensity of Grp75 and Grp78 has been evaluated through an optic microscope Olympus 
BX50 and Image Pro Plus 4.5.1, Immagini e Computer, Milano, Italy, and has been quantitatively 
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analized. Optical density (IOD) has been calculated for arbitrary areas measuring 10 areas for each 
sample 40x.  
 
Evaluation of Macrophage infiltration: CD68 and CD 163. 
Primary antibody: Invitrogen Human Anti CD 68 Clone KP1 (no dilution; 100 microliter for slide); 
Leica Novocastra Human Anti CD163, clone 10D6 (room temperature incubation for 60 minutes; 
dilution 1:1000 in PBS buffer 0.1M pH7.4, 5% normal goat serum; 100 microliter for slide); 
Secondary antibody: SignalStain Boost IHC detection reagent HRP Mouse from Cell Signaling (30 
minutes at room temperature); 
Analysis: macrophage count has been conducted manually, through an optic microscope Olympus 
BX50, and images have been acquired through photo camera Imagin Qicam fast 1394, Image Pro 
Plus  softwer version 7.0. 
 
Evaluation of adipocytes myocardial infiltration: Perilipin1;  
Evaluation of intra myocyte LD: Perlipin2; 
Primary antibody: Cell Signaling Human Anti Perilipin1 (overnight 4°C incubation; dilution 1:1000 
SignalStain Antibody Diluent Cell Signaling; 100 microliter for slide); SBio LifeSpan BioSciences 
Human Anti Perilipin2 (overnight 4°C incubation; dilution 1:1000 in PBS buffer 0.1M pH7.4, 5% 
normal goat serum; 100 microliter for slide); 
Secondary antibody: DAB substrate from Vector Labs (5 minutes at room temperature; 200 
microliter per slide); 
Analysis: Intensity of PLIN1 and PLIN2 has been evaluated through an optic microscope Olympus 
BX50, and images have been acquired through photo camera Imagin Qicam fast 1394, Image Pro 
Plus  softwer version 7.0, red green blue channels, with conversion to 8 bit images. IOD has been 
calculated for arbitrary areas measuring 10 areas for each sample 40x.  
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Statistic analysis 
All results are reported as mean ± SD. Logarithmic transformation was performed on serum 
adiponectin, leptin, mRNA levels to normalize the distribution. Comparisons between the 2 groups 
of patients were performed using Student’s 2-tailed unpaired test. Relation between variables were 
evaluated by simple correlation coefficients and by stepwise multiple regression analysis. 
 
4.2 Results 
Characteristics of the subjects are summarized in Table II. There was no difference in age and 
height between CAD and nonCAD, whereas the CAD group had significantly higher percentage of 
diabetic subjects, higher waist and BMI. Circulating levels of adiponectin were significantly lower 
and circulating levels of leptin were significantly higher in CAD subjects than in nonCAD. 
Regarding drugs, Statins (CAD 23 (85%) vs nonCAD 5(28%)), Insulin (CAD 7 (26%) vs nonCAD 
0) and oral anti-diabetics (CAD 10 (37%) vs nonCAD 0) were significantly more common in CAD 
subjects then in nonCAD. No difference was found between CAD and nonCAD regarding ACE-I 
and Statins. 
 
Variables CAD  
M±SD 
(n 27) 
nonCAD 
M±SD  
(n 18) 
 
total 
M±SD  
(n 45) 
 
p 
Age 65.6 ± 8.1 64.9 ± 9.5 65.4 ± 8.6 0.797 
DM2 17 (63%) 3 (17%) 20 (22.5%) 0.002 
Height (cm)  170.6 ± 5.6 171.9 ± 8.7 171.1 ± 6.9 0.55 
Waist (cm) 102.2 ± 12.7 94.5 ± 12.4 99.3 ± 13 0.06 
BMI (kg/m
2
) .  28.6 ± 5.5 25.6 ± 3.3 27.3 ± 4.9 0.045 
Adiponectin (ug/mL) 11.4 ± 12.6 24.3 ± 25 16.7 ± 20.1 0.014 
Leptin (ng/mL) 7.8 ± 7.9 
 
3.4 ± 2.1 
 
6 ± 6.6 0.010 
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Table II. 
 
 
Both PLIN1 and PLIN2 resulted to be significantly higher in CAD subjects (respectively: 
0.32±0.04 vs 0.28±0.05; p<0.01; 0.27±0.05 vs 0.22±0.05; p<0.01); as well as Grp 78, CD68 and 
CD163 (respectively: 1.48±0.51 vs 1.1±0.38; p<0.01; 1.43±0.51 vs 0.94±0.51; p<0.01). Grp75 
showed a tendency, but was not significant (Figure 7). Even after adjusting the model for DM2 or 
BMI Grp78, the difference in PLIN1 and PLIN2 between CAD and nonCAD remained significant, 
whereas the difference in CD68 and CD163 between the two groups did not. In Table III are shown 
the correlations between the variables. Circulating levels of adiponectin were significantly 
negatively correlated to Grp78, Grp75, PLIN1 and PLIN2. PLIN2 resulted correlated to BMI. 
Stepwise regression analysis was performed using PLIN1 as dependent variable, and BMI, age, 
DM, serum adiponectin, serum leptin, PLIN2, Grp75, Grp78, CD68, CD163 as independent 
variables for all subjects. Only serum adiponectin entered the regression (r=.540, p<0.05). Stepwise 
regression analysis was performed using PLIN2 as dependent variable, and BMI, age, DM, serum 
adiponectin, serum leptin, PLIN1, Grp75, Grp78, CD68, CD163 as independent variables for all 
subjects. Only serum DM entered the regression (r=.483, p<0.05)  
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Table III 
 Serum 
Adipone
ctin 
BMI Età Grp 78 Grp 75 PLIN 1 PLIN 2 CD68 CD163 
Serum 
Adiponectin 
1 
 
n45 
        
BMI -.054 
.727 
n45 
1 
 
n47 
       
Età .002 
.991 
n45 
-.060 
.686 
n47 
1 
 
n48 
      
Grp 78 -637** 
.000 
n27 
.225 
.249 
n28 
.129 
.514 
n28 
1 
 
n28 
     
Grp 75 -.544** 
.003 
n27 
-.011 
.957 
n28 
.015 
.938 
n28 
.810** 
.000 
n28 
1 
 
n28 
    
PLIN 1 -.609** 
.002 
n23 
.343 
.101 
n24 
.081 
.702 
n25 
.252 
.324 
n18 
.344 
.162 
n18 
1 
 
n25 
   
PLIN 2 -.480** 
.003 
n36 
-.408* 
.011 
n38 
-.165 
.315 
n39 
.393 
.052 
n25 
.115 
.585 
n25 
.334 
.120 
n23 
1 
 
n39 
  
CD68 -.059 
.716 
n41 
-.008 
.959 
n43 
.215 
.162 
n44 
.105 
.602 
n27 
-.019 
.927 
n27 
.137 
.523 
n24 
.083 
.620 
38 
1 
 
n44 
 
CD163 -.226 
.155 
41 
.036 
.821 
n43 
.219 
.154 
n44 
.205 
.304 
n27 
.077 
.702 
n27 
.298 
.158 
n24 
.193 
.247 
n38 
.945** 
.000 
n44 
1 
 
n44 
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Figure 7. Immunohistochemistry of Myocardium in nonCAD and CAD subjects (10x); and 
statistical analysis.  
 
 
4.3 Discussion 
 
In paper 1 and 2 we evaluated the characteristics of EAT. The recent results are focused on the 
characterization of  atrial myocardium in patient with and without CAD, through 
immunohysochemistry analysis. 
Our evaluation of myocardial fat infiltration was focused on the identification of two different kind 
of TG accumulation: adipocyte infiltration among myocardiocites, as well as intramyocardioctes 
lipid droplets (LDs) infiltration.  
We found that CAD subjects compared to nonCAD, have significantly higher adipocyte infiltration 
and LDs infiltration, as well as significantly higher markers of ER stress and MGs infiltration. 
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TG are stored in multiple minute LDs, with a core of lipid and a monolayer of phospholipids, free 
cholesterol (FC), and proteins. The most abundant proteins in LDs are the PAT family proteins, 
which take the name from the founding member, Perilipin (Paul 2008), involved in the hormone-
stimulated lipolysis and regulated by peroxisome proliferator-activated receptors (PPARs).  
Perilipin1 (PLIN1) is selectively expressed by adipocytes and steroidogenic cells, whereas 
Perilipin2 (PLIN2) has been described ubiquitously on mammary tissues on myocardial LDs and 
not on adipocytes (Yamaguchi 2006). Analyzing muscular biopsies, it has been seen that PLIN1 is 
located among myofiber on the LD membrane of the intramuscular adipocytes, whereas PLIN2 is 
located within myofibers with high lipid content. (Gandolfi 2011) PLIN1 is indeed considered a 
marker of vital and mature adipocytes, whereas PLIN 2 is considered a marker of LD (Gandolfi 
2011, Yamaguchi 2006). According to our results CAD subjects had a significant higher amount of 
both PLIN-1 and PLIN-2.  
 
The consequent accumulation of lipotoxic lipid products, leads to lipotoxicity,  that can mediate 
both apoptosis and oncotic cell death in cardiomyocytes (Kong 2003), impairing contractile 
function and organ dysfunction. In animal models of obesity and diabetes mellitus, 
intramyocardial lipid accumulation has been demonstrated to be related to decreased myocardial 
function, primarily associated with diastolic dysfunction (Christoffersen 2003).  
Given the fact that the induction of apoptosis in just 0.02% of myocytes is sufficient to cause a 
lethal, dilated cardiomyopathy (Wencker 2003), it’s easy to understand the growing interest in 
understanding the relationship between the fat and the heart. 
Mitochondrial and ER dysfunctions seem to be kay mechanism leading to cell death in myocardial 
lipotoxicity. Obesity is associated with an increment of the number and a change in the morphology 
of adipocytes mitochondria. This mechanism is supposed to make front to the higher energy 
request, but these mitochondria don’t express higher genes involved in the oxidative 
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phosphorylation, showing reduced production of ATP (The mitochondrial pathway seems to be 
linked to activation of caspase and mitochondrial loss of cytochrome c. The increase in 
mitochondrial number, supposed to be a supplying mechanism to the higher energy request, occurs 
without a concomitant increase in the expression of nuclear-encoded genes that encode oxidative 
phosphorylation subunits. These mitochondria shows reduced oxidative capacity for glucose and 
ATP generation, resulting in dysfunctional mitochondria (Kim 2006; Wende 2010).  
A well known marker of mitochondrial dysfunction is Grp75 (Hayashi 2009). Grp78 is on the other 
hand altered when incorrect protein folding occurs. When there is a mismatch between the UPR and 
protein translation, ER stress ensues and may ultimately lead to cell death. Grp78 is indeed used as 
marker of ER stress (Gregor 2007). 
Supporting this thesis our results show that CAD subjects express significantly higher amounts of 
Grp78 and have a tendency of a higher expression of Grp75.  
Cell disfunction and death can lead to MG infiltration.  
Only few studies have evaluated EAT MG infiltration. Markers of macrophage infiltration seem to 
be higher in EAT of CAD patients, with a relevant component of M2-like MG (Sacks 2011). More 
specificity Hirata et al evaluated cell surface markers and cytokine expression in EAT and SAT in 
patients with and without CAD (Hirata 2011). CD68 (panMG marker) was significantly higher in 
CAD, and interestingly no only M1 but also M2 resulted higher in CAD EAT; the ratio M1/M2 was 
positively correlated with the severity of CAD, showing a relative increase in M1 and a relative 
decrease in M2 in EAT CAD (Hirata 2011).  
Infiltration of MG in the myocardium has been described in advanced stages of myocardial 
infarction (Akasaka 2006) and in subjects with apoptotic cell death during acute rejection in heart 
transplants (Ozdemin 200), but it has not been well characterized in CAD.  
In our subjects we analyzed CAD68 expression as a marker of panMG infiltration and CD163 as a 
marker of M2 infiltration. According to our results the myocardium of CAD subjects is 
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significantly more infiltrated by MG compared to nonCAD subjects. M2 infiltration results to be 
also significantly higher in CAD.  
The role of M2 infiltration could be considered as an attempt of tissue repairmen. Recently it has 
been discussed about the effective antiinflammatory activity of M2 in different tissues. 
Flow citometry of AT MG pointed out how different AT depots express higher amount of CD163 
MG; in vitro differentiated AT MG showed a surprising proinflammatory secretion pattern from M2 
(Zeyda 2007). This founding drove the researchers to the conclusions that AT MG comprise a 
particular macrophage type that has M2 surface characteristics but that produces extensive amounts 
of inflammatory cytokines (Zeyda 2007). 
More studies are needed to better elucidate MG infiltration in the myocardium and its significance. 
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6.     Effect of moderate weight loss on hepatic, pancreatic and visceral lipids in obese subjects. 
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